NCT00431756View on ClinicalTrials.gov

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

May 1, 2002

Primary Completion Date

May 1, 2023

Study Completion Date

December 1, 2025

Conditions
Barrett EsophagusEsophageal NeoplasmGastroesophageal Reflux
Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Johns Hopkins University

OTHER

NCT00431756 - Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus | Biotech Hunter | Biotech Hunter